Physician profile
Lara E Rosenbaum
NPI 1922360601
$2,330.79
in general payments reported to CMS, 2019-2025
23 companies · $282 in 2025
The $282 reported for 2025 was less than what a typical Mohs-Micrographic Surgery provider received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $348 · 2020: $89.74 · 2021: $314 · 2022: $506 · 2023: $374 · 2024: $417 · 2025: $282.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,073.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,073.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $594.57 | 2019-2025 | Rinvoq, Skyrizi |
| Janssen Biotech, INC. | $239.62 | 2020-2025 | Tremfya, Simponi Aria, Simponi |
| Incyte Corporation | $209.87 | 2021-2025 | Opzelura |
| Lilly USA, LLC | $155.30 | 2021-2024 | Olumiant, Taltz |
| Sun Pharmaceutical Industries INC. | $139.83 | 2019-2025 | |
| Amgen INC. | $139.08 | 2020-2022 | |
| Celgene Corporation | $131.72 | 2019 | |
| Novartis Pharmaceuticals Corporation | $100.24 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $93.56 | 2021-2025 | Dupixent, Libtayo |
| Ucb, INC. | $92.18 | 2022-2025 | Bimzelx, Cimzia |
| Galderma Laboratories, L.P. | $64.49 | 2019 | |
| Genzyme Corporation | $56.62 | 2021-2025 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $49.44 | 2019-2022 | |
| Allergan, INC. | $47.71 | 2019 | |
| Leo Pharma INC. | $40.41 | 2024-2025 | Adbry |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lnhc, INC | $40.18 | 2025 | Zelsuvmi |
| Krystal Biotech INC | $27.57 | 2023 | Vyjuvek |
| Boehringer Ingelheim Pharmaceuticals, INC. | $24.99 | 2023 | Spevigo |
| Biofrontera INC. | $21.26 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $18.59 | 2025 | Sotyktu |
| Dermira, INC. | $18.07 | 2019 | |
| Organogenesis INC. | $17.32 | 2022 | |
| Advanced Oxygen Therapy INC. | $8.17 | 2024 | Topical Oxygen Chamber For Extremities |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lara Rosenbaum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.